2024-01-23 07:15:00 ET
Summary
- Pfizer stock is popular among dividend growth investors due to its 14-year dividend growth streak and 6% yield.
- The company has strong underlying fundamentals, including an A credit rating from S&P and a proven track record of innovation.
- However, I am still not bullish on the stock despite the steep recent sell-off.
- In this article, I list several reasons why.
Pfizer ( PFE ) stock is an increasingly popular option for dividend growth investors due to its 14-year dividend growth streak, strong balance sheet, 6% yield, and what appears to be a deeply discounted stock price after the stock's brutal sell-off over the past two years:
Read the full article on Seeking Alpha
For further details see:
Why I'm Avoiding 6%-Yielding Pfizer Stock